Kathryn Boylan
Houston, TXNPI 1275113961
Payments from drug & device makers
$4,544in general payments, 2019–2025
Across 206 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$521
- AstraZeneca$391
- CSL Behring$390
- Genentech USA, Inc.$388
- Novartis$344
- Takeda Pharmaceuticals U.S.A., Inc.$265
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,49499%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 19 | $521 |
| AstraZeneca(2 entities) | 19 | $391 |
| CSL Behring | 17 | $390 |
| Genentech USA, Inc. | 20 | $388 |
| Novartis | 16 | $344 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $265 |
| AbbVie | 14 | $262 |
| Acadia Pharmaceuticals Inc | 11 | $235 |
| Eisai Inc. | 8 | $229 |
| Argenx US, Inc. | 9 | $224 |
| Biogen | 9 | $165 |
| Otsuka America Pharmaceutical, Inc. | 8 | $160 |
| Sanofi | 7 | $154 |
| Amgen | 5 | $124 |
| EMD Serono, Inc. | 6 | $107 |
| Tanabe Pharma America, Inc. | 6 | $91 |
| Merz Pharmaceuticals, LLC | 4 | $84 |
| Johnson & Johnson(2 entities) | 3 | $81 |
| Springworks Therapeutics, Inc. | 3 | $76 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $68 |
| Pfizer | 4 | $62 |
| Catalyst Pharmaceuticals, Inc. | 1 | $24 |
| Neurelis, Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $23 |
| Amicus Therapeutics, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Microtransponder, Inc. | 1 | $14 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.